Chemoinformaics analysis of Kaempferol 4-O-glucoside
| Molecular Weight | 448.38 | nRot | 4 |
| Heavy Atom Molecular Weight | 428.22 | nRig | 24 |
| Exact Molecular Weight | 448.101 | nRing | 4 |
| Solubility: LogS | -3.679 | nHRing | 2 |
| Solubility: LogP | 0.582 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 11 | APOL | 57.2279 |
| nHD | 7 | BPOL | 26.1401 |
| QED | 0.279 |
| Synth | 3.871 |
| Natural Product Likeliness | 1.974 |
| NR-PPAR-gamma | 0.783 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.465 |
| HIA | 0.596 |
| CACO-2 | -6.205 |
| MDCK | 0.00000813 |
| BBB | 0.025 |
| PPB | 0.918336 |
| VDSS | 0.884 |
| FU | 0.0881054 |
| CYP1A2-inh | 0.207 |
| CYP1A2-sub | 0.035 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.043 |
| CYP2c9-sub | 0.196 |
| CYP2d6-inh | 0.321 |
| CYP2d6-sub | 0.161 |
| CYP3a4-inh | 0.106 |
| CYP3a4-sub | 0.017 |
| CL | 2.832 |
| T12 | 0.889 |
| hERG | 0.136 |
| Ames | 0.814 |
| ROA | 0.04 |
| SkinSen | 0.273 |
| Carcinogencity | 0.253 |
| EI | 0.089 |
| Respiratory | 0.032 |
| NR-Aromatase | 0.937 |
| Antiviral | Yes |
| Prediction | 0.955567 |